TECO 2030 completes production of the first stack in Narvik
NARVIK, Norway, May 15, 2023 (GLOBE NEWSWIRE) -- TECO 2030 (OSE: TECO, OTCQX: TECFF, ISIN: NO0010887516) completes the first manual fuel cell stack production in Narvik. The TECO 2030 Fuel Cell stack is a 100kW Proton Exchange Membrane (PEM) fuel cell stack purposely developed for marine, heavy duty, stationary or mobile power applications.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
Stack0001Narvik: The first ever TECO 2030 fuel cell stack built in Narvik.
“We are now making a transition into commercial production of the first fuel cell stacks at our own facility in Narvik. This is a big milestone, and I am grateful for what the team has achieved together with our strong partners. Today we can offer the first bottom-up developed marine and heavy-duty PEM fuel cell technology,” says Tore Enger, Group CEO, TECO 2030. “This brings us one step closer to cleaner operations in energy intensive industries such as marine shipping, and mobile and stationary heavy-duty applications with a scalable plug and play solution ranging from 400kW’s and upwards.”
Among the first TECO 2030 fuel cell stacks, which is being deployed, is an Implenia Norway’s 800kW HydroPilot container, which will be in operation end of 2023. A land-based stationary fuel cell application to provide renewable power output for demonstrating a zero-emission power generator at a construction site. The HydroPilot container is funded by the Norwegian state-owned funding company ENOVA SF with approx. EUR 1.5 million.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
TECO 2030 Fuel Cells: On the left is an illustration of Implenia’s HydroPilot container and on the right is HyEkoTank project for Tarbit Shipping and Shell.
Following the production of Implenia’s container, TECO 2030’s Narvik team will start the production of the fuel cell stacks for the EU-funded Horizon Europe HyEkoTank project. HyEkoTank will demonstrate the world’s first and largest 2.4 MW marine fuel cell system for a retrofit installation onboard a product tanker owned by Tarbit Shipping AB sailing on charter to a Shell plc subsidiary.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
Cutting the ribbon: Rune Karlsen (right), Managing Director at TECO 2030 Innovation Center, cutting the ribbon together with Ingrid Martenson Bortne (left) from Innovation Norway at the giga factory opening ceremony. Photo: Øyvind Paulsen, hydrogen24.no.
The 100kW fuel cell stacks, which are now being produced at the TECO 2030 Innovation Center in Narvik, are designed with cutting-edge fuel cell technologies, optimized for high efficiency and durability. TECO 2030's fuel cell systems can easily be adapted and customized to meet specific power requirements in a variety of heavy applications. This flexibility allows for seamless integration into a diverse portfolio of applications, ranging from maritime and transportation to industrial sectors.
TECO 2030 is building up Europe's first giga production facility of hydrogen PEM fuel cell stacks and modules in Narvik, Norway. The production capacity will be built up through 2023 and early 2024, targeting an output capacity of up to 120 MW of fuel cells in 2024, 400 MW in 2025 and 1.6 GW in 2030.
TECO 2030 is committed to continue its mission towards zero emission by eliminating and reducing the harmful emissions in several heavy-polluting industries.
Contact:
Tore Enger, Group CEO, +47 920 83 800, tore.enger@teco2030.no
About TECO 2030:
TECO 2030 is building up Europe's first giga production facility of hydrogen PEM fuel cell stacks and modules in Narvik, Norway. The production capacity will be built up through 2023 and early 2024, targeting an output capacity of 120 MW of fuel cells in 2024, 400 MW in 2025 and 1.6 GW in 2030.
TECO 2030 is a Norwegian based clean tech company developing zero-emission technology for the maritime and heavy industry. We are developing PEM hydrogen fuel cell stacks and PEM hydrogen fuel cell modules, that enable ships and other heavy-duty applications to become emissions-free. The company is listed on Euronext Growth on Oslo Stock Exchange under the ticker TECO and in New York, OTCQX under the ticker TECFF. TECO 2030 is a spinoff from TECO Maritime Group, a group that has provided technology and services to the global shipping industry since 1994. For more information, please visit www.teco2030.no.
Photos accompanying this announcement are available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/2523ac38-003c-4fb6-8a61-d234cebf8324
https://www.globenewswire.com/NewsRoom/AttachmentNg/1bdd25c2-ed2b-43ea-8685-074d9d02cf4c
https://www.globenewswire.com/NewsRoom/AttachmentNg/cf93f01c-6142-463c-815b-0cd24f0511b1
A video accompanying this announcement is available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/49cd75c3-da0c-4918-87f5-5fe021b83961
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
RevoluGROUP Announces CEO and Director Stepping Down3.5.2024 00:25:00 CEST | Press release
VANCOUVER, British Columbia and BARCELONA, Spain., May 02, 2024 (GLOBE NEWSWIRE) -- RevoluGROUP Canada Inc. (TSX- V: REVO), (Frankfurt: IJA2), (Munich: A2PU92) ("RevoluGROUP") today announced CEO and Director, Gavin McMillan, will be stepping down from his positions, effective immediately. Gavin joined the Company in August 2023 and served as CEO for over six months. During his leadership, McMillan has been instrumental in focusing on the continued development of the API-driven Payment-as-a-Service (PaaS) model, which has continued to expand through key white-label partnerships and joint venture agreements and enhancing revenue streams. In a statement, Bernard Lonis, the Chairman of the Board, acknowledged McMillan's vital contributions and leadership, stating, "We owe a great deal of gratitude to Gavin for his dedication and the continued strong foundation he has helpedtobuildforRevoluGROUP'sfuture. We wish Gavin the best in his future endeavors." The Board has commenced a comprehensi
Novotech Appoints Commercial and Clinical Life Sciences Specialist to Head Up Global Drug Development Consulting Team2.5.2024 23:00:15 CEST | Press release
BOSTON, May 02, 2024 (GLOBE NEWSWIRE) -- Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has appointed Scott Schliebner as Vice President and Global Head, Drug Development Consulting (DDC). Novotech’s Chief Medical Officer Dr. Judith Ng-Cashin stated: “We welcome Scott to the medical and scientific team. He is a proven strategic, innovative, and business focused life sciences executive with ~30 year of experience across the biopharma and CRO sectors. He brings valuable leadership to our world-class DDC team, a full-service global drug development and strategic regulatory team providing comprehensive "inception to approval" services.” The DDC partners with biotechs to optimize a fit-for purpose therapeutic development strategy that both advances the development program and creates value for the company. To do this, DDC leverages CMC/manufa
Brookfield Reinsurance Completes Acquisition of AEL2.5.2024 22:10:00 CEST | Press release
BROOKFIELD, NEWS, May 02, 2024 (GLOBE NEWSWIRE) -- Brookfield Reinsurance (NYSE, TSX: BNRE, BNRE.A) and American Equity Investment Life Holding Company (NYSE: AEL) (“AEL”) today announced the completion of Brookfield Reinsurance’s acquisition of AEL in a cash and stock transaction valued at $56.50 per AEL share. AEL’s leading fixed annuity business bolsters Brookfield Reinsurance’s expanding insurance operations and increases its insurance assets under management to over $100 billion. Jon Bayer, Managing Partner at Brookfield Reinsurance said, “We are excited to welcome AEL to our organization as we continue to grow, diversify and scale our retirement services capabilities. AEL’s strong franchise and track record of serving policyholders and distribution partners, coupled with the scale of our existing platform and offerings, will position us well for the next phase of growth.” Brookfield Reinsurance expects to maintain AEL’s headquarters in Des Moines, Iowa, and its growth in the fixe
Fortinet Reports First Quarter 2024 Financial Results2.5.2024 22:05:43 CEST | Press release
First Quarter 2024 Highlights Total revenue of $1.35 billion, up 7% year over yearService revenue of $944 million, up 24% year over yearGAAP operating margin of 23.7%Non-GAAP operating margin of 28.5%1Cash flow from operations of $830 millionFree cash flow of $609 million1 SUNNYVALE, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Fortinet® (Nasdaq: FTNT), a global cybersecurity leader driving the convergence of networking and security, today announced financial results for the first quarter ended March 31, 2024. “We are diligently executing on our strategy announced six months ago to leverage our scale, go-to-market capabilities, customer-first focus, and engineering expertise to capitalize on the fast-growing Unified SASE and Security Operations markets while continuing to gain market share in Secure Networking,” said Ken Xie, Founder, Chairman and Chief Executive Officer of Fortinet. “We believe our Unified SASE offering is the most comprehensive in the industry and we are well-positioned
Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial Results2.5.2024 22:05:00 CEST | Press release
Reported $420.5 million in cash resources as of March 31, 2024, which when combined with certain anticipated regulatory milestone payments provides projected cash runway into 2H 2027Completion of rolling biologics license application (BLA) filing with the U.S. Food and Drug Administration (FDA) for zanidatamab as second-line treatment for biliary tract cancers (BTC) in the United States (U.S.) by our partner, Jazz PharmaceuticalsExpected initiation of a Phase 3 clinical trial for zanidatamab in the second half of 2024, for breast cancer patients who have progressed on trastuzumab deruxtecan (T-DXd), by our partner, Jazz Pharmaceuticals Two planned investigational new drug (IND) and foreign equivalent submissions in 2024 for ZW191 and ZW171Acceptance of an abstract for zanidatamab in BTC at the American Society of Clinical Oncology (ASCO) annual meeting submitted by our partner, Jazz PharmaceuticalsPresentation of five abstracts at the American Association for Cancer Research (AACR) ann